The Carrier Screening Market is experiencing extraordinary momentum as awareness of genetic health grows and demand for preventive healthcare solutions reaches unprecedented levels. According to research from SNS Insider, the market, which was valued at USD 2.26 billion in 2023, is forecasted to expand to USD 11.44 billion by 2032, representing an impressive compound annual growth...

The Direct-to-Consumer Genetic Testing Market is undergoing a dramatic transformation as consumer interest in personalized health insights, ancestry tracing, and genetic risk assessment continues to accelerate. Valued at USD 1.71 billion in 2023, the market is forecast to grow at a striking compound annual growth rate (CAGR) of 17.64%, reaching USD 7.59 billion by 2032. This...